Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...
Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...
Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...
In ongoing trials of Eli Lilly’s next-generation obesity drug, several trial participants are running into an issue they never expected: They are losing too much weight. One participant lost 22% ...
Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big ...
Signal transducer and activator of transcription 6 (STAT6) is a member of the STAT family involved in the regulation of ... Researchers from Recludix Pharma Inc. have presented the preclinical ...
After a Canadian regulator began requiring application fees from drug companies more than a decade ago, the odds that a drug — other than cancer treatments — would receive a recommendation for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback